Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
06/2010
06/23/2010CN101748120A Interference RNA interfering muscle specific E3 ubiquitin protein ligase gene, carrier containing same and application thereof
06/23/2010CN101748096A Sub totipotential stem cell and preparation method and application thereof
06/23/2010CN101747451A Targeted adhesion chitosan material and application thereof
06/23/2010CN101747422A Schistosoma japonica fatty acid-binding protein and coding gene and application thereof
06/23/2010CN101745151A Gene-activated poly-lactic acid material for treating liver diseases and preparation method thereof
06/23/2010CN101745123A Method for preparing anti-cancer medicament capable of carrying out automatic synthesis and target release
06/23/2010CN101745122A Automatic synthesis anti-cancer drug preparation method based on microfluidic chip
06/23/2010CN101745121A Genetic therapy breast cancer drug preparation method based on microfluidic chip
06/23/2010CN101745120A Application of miRNA-320 in preparing preparation for promoting apoptosis of tumor cells
06/23/2010CN101745111A Method for restraining infiltration and metastasis of breast cancer cells by using target CCL 18 and application thereof
06/23/2010CN101744848A Application of FHL3 (four and a half LIM domains 3) in preparation of medicines for treating tumors
06/23/2010CN101744768A Protein or nucleic acid drug liposome preparation and preparation method thereof based on tetraether lipid
06/23/2010CN101744766A Preparing technique of nano magnetic gene-loaded liposome of temperature-controlled release
06/23/2010CN101744650A System for transferring anti-hepatitis b virus vaccine
06/23/2010CN101744649A System for transferring anti-AIDS vaccine
06/23/2010CN101205545B Recombinant baculoviral for expressing grass carp reovirus external casing protein and construction thereof
06/22/2010US7741470 siRNA targeting gremlin
06/22/2010US7741468 protein hLRTM4 and the polynucleotide which encodes it; used to treat liver injury, hepatocellular carcinoma
06/22/2010US7741465 Chimeric receptor genes and cells transformed therewith
06/22/2010US7741452 produced by introducing amino acid mutation(s) so that no glycosylation take place at at least one glycosylation site of hepatocyte growth factor; more stable in the blood circulation
06/22/2010US7741447 Antibody against tumor specific antigen as target
06/22/2010US7741445 Multidrug resistance proteins; xenobiotic transporters; counteracting the mechanism of drug resistance so to provide a longer and more effective course of chemotherapeutic drug treatment for cancer patients
06/22/2010US7741440 Apoptin-associating protein
06/22/2010US7741439 Isolated stra6 polypeptides
06/22/2010US7741340 Hydroxy piperidine derivatives to treat gaucher disease
06/22/2010US7741310 A polynucleotide encodes an arginase, a nerve growth factors for treating nervous system disorders, neurodegenerative diseases
06/22/2010US7741309 for treating prostatic, breast or lung carcinoma
06/22/2010US7741305 antisense therapy; for diagnosis and treatment of atherosclerosis, hypercholesterolemia, or coronary artery disease
06/22/2010US7741303 Stimulation of cellular regeneration and differentiation in the inner ear
06/22/2010US7741302 cis-element of Oryzias Latipes Tol2 element (inverted terminal repeat sequences); plasmids
06/22/2010US7741301 Transposase and method of gene modification
06/22/2010US7741300 Methods of using nucleic acid vector-lipid complexes
06/22/2010US7741271 atopic diseases such as allergies, asthma, eosinophilia, glomerulonephritis; hyperplastic conditions such as cancer; T cell immunologobulin and mucin domain (TIM)
06/22/2010US7741112 nucleic acid comprising a sequence encoding a mitochondrial localization signal from subunit VIII of human cytochrome oxidase operably linked to a sequence encoding a viral receptor
06/22/2010US7741111 CaM multi-functional protein kinase; for systematic study of the role of protein kinases in mammary gland development and carcinogenesis
06/22/2010US7741080 elucidate the functional mechanism of adipocyte hypertrophy-dependent suppression of adiponectin production; identifies factors that can increase the expression of adiponectin gene; provides adiponectin expression-inducing agents; metabolic or heart diseases
06/22/2010US7741077 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
06/22/2010US7741057 Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor
06/22/2010US7741030 detecting whether CpG sequences in a region from base 374 to base 592 in a DR3 gene promoter region obtained from synovial cells or synovial infiltrating lymphocytes of the human subject are methylated or not
06/22/2010US7741026 Baculovirus expressing the exogenous nucleotide sequence porcine circovirus-B (PCVB) open reading frame 2; transformed host cells for expressing immunogenic protein for protecting pigs including pregnant pigs
06/22/2010US7740871 Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine
06/22/2010US7740866 Baculovirus expressing the exogenous nucleotide sequence porcine circovirus-B (PCVB) open reading frame 2; transformed host cells for expressing immunogenic protein for protecting pigs including pregnant pigs; adjuvant
06/22/2010US7740865 Circovirus sequences associated with piglet weight loss disease (PWD)
06/22/2010US7740864 Vaccines for diseases of fish
06/22/2010US7740861 extracted yeast cell wall comprising beta-glucan, a payload molecule(e.g.polynucleotides, polypeptides, proteins, and drugs) and a payload trapping molecule ( e.g polysaccharides, polyamides, polyacrylamide, cationic and anionic polymers, detergents); both in vivo/in vitro delivery of polyload molecule
06/22/2010US7740837 Genetically modified cells expressing a TGF beta inhibitor, the cells being lung cancer cells
06/22/2010US7740836 using genetic constructs and adeno-associated viral vectors for the transfer of Oa1 gene to the retina of patients affected by ocular albinism type I
06/22/2010US7740835 Using a Bifidobacterium as a gene delivery vector for a recombinant DNA in combination with an antitumor agent to tumor tissues under anaerobic conditions
06/22/2010US7740830 Imaging, diagnosis and treatment of disease
06/22/2010CA2447300C Cell-specific replication-competent vector
06/22/2010CA2441071C Tsg101-gag interaction and use thereof
06/22/2010CA2395493C Hyaluronic acid in the treatment of cancer
06/22/2010CA2337491C Human mink gene mutations associated with arrhythmia
06/22/2010CA2323073C Uses for human non-autologous mesenchymal stem cells
06/22/2010CA2265480C Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (hnf) 1 alpha (.alpha.), hnf-1.beta. and hnf-4.alpha.
06/22/2010CA2256483C P13 lipid kinase
06/17/2010WO2010067811A1 CONSTRUCTION OF PROTEIN-RESPONSIVE shRNA/RNAi REGULATION SYSTEM UTILIZING RNP MOTIF
06/17/2010WO2010067755A1 Therapeutic agent for hypertension, method for treating hypertension, method for diagnosing hypertension, and method for screening therapeutic agent for hypertension
06/17/2010WO2010067617A1 Lipid membrane structure
06/17/2010WO2010067041A1 Modification of nucleic acid vectors with polymers comprising charged quaternary amino groups
06/17/2010WO2010066858A1 Methods for the treatment and the prognosis of cancer
06/17/2010WO2010066112A1 siRNA COMPOSITIONS AND METHODS FOR POTENTLY INHIBITING VIRAL INFECTION
06/17/2010WO2010066046A1 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
06/17/2010WO2010066018A1 Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer
06/17/2010WO2009152480A3 Methods to treat solid tumors
06/17/2010US20100152281 Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal function
06/17/2010US20100152113 Metal-binding therapeutic peptides
06/17/2010US20100152095 Wound healing
06/17/2010US20100152064 siRNA targeting BCL2L1
06/17/2010US20100151576 Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors
06/17/2010US20100151524 Compositions and Methods for Increasing Bone Mineralization
06/17/2010US20100151466 Diagnosis and treatment of cervical cancer
06/17/2010US20100151458 Oligoribonucleotides and ribonucleases for cleaving rna
06/17/2010US20100151006 Cancer therapy sensitizer
06/17/2010US20100150909 PTHrP-DERIVED MODULATORS OF SMOOTH MUSCLE PROLIFERATION
06/17/2010US20100150901 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
06/17/2010US20100150893 Methods of organ regeneration
06/17/2010US20100150888 Cells for joint fluid
06/17/2010US20100150884 Anticancer Agent to Be Combined with Telomelysin
06/17/2010US20100150878 Dermal micro-organs, methods and apparatuses for producing and using the same
06/17/2010CA2746339A1 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
06/17/2010CA2745849A1 Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer
06/17/2010CA2744959A1 Modification of nucleic acid vectors with polymers comprising charged quaternary amino groups
06/17/2010CA2744938A1 Modification of nucleic acid vectors
06/17/2010CA2688804A1 Polycistronic vector for human induced pluripotent stem cell production
06/16/2010EP2196473A1 Mycobacterial antigens expressed during latency
06/16/2010EP2196472A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
06/16/2010EP2195425A1 Pkib and naaladl2 for target genes of prostate cancer therapy and diagnosis
06/16/2010EP2195035A1 High concentration chitosan-nucleic acid polyplex compositions
06/16/2010EP2195029A2 Treatment and prevention of neurodegenerative diseases
06/16/2010EP1234024B2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus
06/16/2010CN1984921B Modulation of survivin expression
06/16/2010CN1882682B Method of preparation of pharmaceutically grade plasmid DNA
06/16/2010CN1857232B Biodegradable nano magnetic capsule loading medicine and its preparing process
06/16/2010CN1512894B Monocyte specific particulate delivery carrier
06/16/2010CN1162978B Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
06/16/2010CN101735981A Process for producing cytotoxic lymphocyte
06/16/2010CN101735418A Biodegradable cationic polymer and application thereof
06/16/2010CN101735383A Zinc oxide quantum dot wrapped by poly(N, N-dimethyamino ethyl methacrylate)-polymethacrylate, preparation and application thereof
06/16/2010CN101735298A Phosphoric acid diester and preparation method thereof
1 ... 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 ... 870